Cargando…
Regulatory T-cell heterogeneity and the cancer immune response
The frequency of circulating or tumour-infiltrating regulatory T cells (Tregs) has been associated with poor patient survival in many cancers including breast, melanoma and lung. It has been hypothesised that Tregs impact the anti-tumour function of effector T cells, resulting in worse outcomes for...
Autores principales: | Ward-Hartstonge, Kirsten A, Kemp, Roslyn A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628269/ https://www.ncbi.nlm.nih.gov/pubmed/28983402 http://dx.doi.org/10.1038/cti.2017.43 |
Ejemplares similares
-
Regulatory T‐cell heterogeneity
por: Ward‐Hartstonge, Kirsten A, et al.
Publicado: (2018) -
Changes in immune cell populations following KappaMab, lenalidomide and low‐dose dexamethasone treatment in multiple myeloma
por: Norton, Samuel E, et al.
Publicado: (2023) -
Multiparametric analysis of colorectal cancer immune responses
por: Leman, Julia KH, et al.
Publicado: (2018) -
Implications of regulatory T cells in anti-cancer immunity: from pathogenesis to therapeutics
por: Dwivedi, Mitesh, et al.
Publicado: (2022) -
Tonic-signaling chimeric antigen receptors drive human regulatory T cell exhaustion
por: Lamarche, Caroline, et al.
Publicado: (2023)